Staphysagria
DELPHINIUM STAPHISAGRIA SEED
ORAL
HUMAN OTC DRUG
Staphysagria is an FDA drug label for the active ingredient DELPHINIUM STAPHISAGRIA SEED manufactured by Boiron administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231115.
- Generic name
- DELPHINIUM STAPHISAGRIA SEED
- Manufacturer
- Boiron
- Product type
- HUMAN OTC DRUG
- Route
- ORAL
- Dosage form
- N/A
- NDC
- 0220-4885
- Application
- N/A
- Label effective
- 20231115
Active ingredients
Staphysagria 30X (**contains 0.443 mg of the active ingredient per pellet)
Indications & Usage
Itching Of Surgical Wounds*
Dosage & Administration
Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.
Contraindications
Not available.
Warnings
Not available.
Adverse Reactions
Not available.